OR7E8P

Across TCGA pan-cancer cohorts, OR7E8P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OR7E8P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher OR7E8P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E8P expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

THCA, BLCA, and GBM are the cancer types where OR7E8P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.951	0.995	<.001	72	view →
BLCA	OS	Tertile	II,III,IV	0.735	0.398	.015	36	view →
GBM	OS	Tertile	All	0.145	0.420	.028	18	view →
KICH	DFS	Tertile	III,IV	0.035	0.772	.021	18	view →
KIRC	DFS	Tertile	II,III,IV	0.258	0.661	.033	18	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	15	view →
PRAD	DFS	Tertile	All	0.672	0.888	.031	12	view →
KIRP	OS	Tertile	All	0.736	0.950	.009	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OR7E8P–THCA (OS)

Open the THCA breakdown →